Skip to content
OpenCapital
Get started

Zimmer Biomet Holdings ZBH Q4 2025 Annual earnings

Reported February 10, 2026 · Before market open

Revenue$2.2BBeat by $19.9MDiluted EPS$2.42Beat by $0.04
Revenue estimate$2.2B
EPS estimate$2.38

Next report

Aug 6, 2026 (In 3 weeks)
Revenue estimate$2.1B
EPS estimate$2.01

Financials

Q4 2025

Income statement

See full
Revenue$2.2B+10.9%
Gross profit$1.5B+1.0%
Operating income$154.5M-60.3%
Net income$139.3M-41.8%
EPS (diluted)$0.71-40.3%

Balance sheet

See full
Cash & equivalents$591.9M+12.6%
Total debt$7.8B+20.2%
Total equity$12.7B+1.8%
Total assets$23.1B+8.1%

Cash flow

See full
Operating cash flow$517.4M+2.2%
CapEx$74.8M+45.2%
Free cash flow$442.6M-2.7%

Valuation & ratios

Valuation

as of 12/31/25
See full
Market cap$17.82B-15.3%
Enterprise value$24.98B-7.3%
P/E25.3×+2.0×
P/S2.2×-0.6×

Profitability

See full
Gross margin69.7%-1.8pp
Operating margin13.3%-3.4pp
Net margin8.6%-3.2pp
FCF margin17.9%+1.0pp

Returns & leverage

See full
Return on equity5.6%-1.6pp
Debt / equity0.6×+0.1×
Current ratio2×+0.1×

Segments

By product

See full
Knees$911.1M+8.6%
SET$587.6M+20.1%
Hips$555.4M+6.8%
Technology And Data Bone Cement And Surgical$189.7M+8.6%

By geography

See full
Americas$1.4B+11.0%
EMEA$501.3M+14.5%
Asia Pacific$329.4M+5.4%

Versus estimates

Revenue

Q1 2026$2.1BBeat by $16.2M
Q4 2025$2.2BBeat by $19.9M
Q3 2025$2.0BMiss by $10.4MQ2 2025$2.1BBeat by $20.5MQ1 2025$1.9BBeat by $13.9MQ4 2024$2.0BBeat by $8.9M

Diluted EPS

Q1 2026$2.09Beat by $0.23
Q4 2025$2.42Beat by $0.04
Q3 2025$1.90Beat by $0.03Q2 2025$2.07Beat by $0.09Q1 2025$1.81Beat by $0.04Q4 2024$2.31Beat by $0.01

Ask the moment Zimmer Biomet Holdings reports.

Connect your AI and ask the moment the filing drops. It reads the release, surfaces what management said, and gives you its own read.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

When did Zimmer Biomet Holdings report Q4 2025 earnings?
Zimmer Biomet Holdings (ZBH) reported Q4 2025 earnings on February 10, 2026 before market open.
What were Zimmer Biomet Holdings's Q4 2025 revenue and EPS?
Zimmer Biomet Holdings reported revenue of $2.2B and diluted EPS of $2.42 for Q4 2025.
Did Zimmer Biomet Holdings beat estimates in Q4 2025?
Revenue beat the consensus estimate of $2.2B by $19.9M. EPS beat the consensus estimate of $2.38 by $0.04.
How did Zimmer Biomet Holdings's Q4 2025 results compare year-over-year?
Compared to the same quarter a year prior, revenue grew 10.9% from $2.0B a year earlier and diluted EPS grew 4.8% from $2.31.
Where can I find Zimmer Biomet Holdings's Q4 2025 SEC filings?
You can read the 8-K earnings release (0001193125-26-043620) and the 10-K periodic report (0001193125-26-059853) directly on SEC EDGAR. The filing index links above go to sec.gov.